Alma DD - Respiro Diagnostics
Registration
Past Event
About Event
- event restricted to Alma Angels -
“Respiro is developing a non-invasive, breath-based diagnostic platform to guide treatment decisions for patients with lung cancer. " Alison Quinn, the founder of Respiro Diagnostics will present the business model and current raise to Alma Angels.
Key areas of interest: Biotech, DeepTech, HealthTech, Life Sciences, TechBio/CompBio
Register to attend the group DD call or to receive the recording if you cannot make that time. You will be added to the DD channel.
You can see the deck and all deal info on the app. Please review the deck ahead of the call and have your questions ready, we will create a shared google doc to aggregate questions and notes.
Looking forward to it!